¹ÌÁֽŰæ Àڱر⠽ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, Àç·á À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Vagus Nerve Stimulators Market, By Product Type, By Application, By Material Type , By End User, By Geography
»óǰÄÚµå : 1671907
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,385,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,933,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,191,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ¹ÌÁֽŰæ Àڱر⠽ÃÀå ±Ô¸ð´Â 2025³â¿¡ 6¾ï 6,740¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 12¾ï 9,310¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â¿¡ CAGR 9.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼ ³»¿ë
±âÁØ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 6¾ï 6,740¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£: 2025-2032³â CAGR: 9.90% 2032³â °¡Ä¡ ¿¹Ãø 12¾ï 9,310¸¸ ´Þ·¯
µµÇ¥. ¹ÌÁֽŰæ Àڱر⠽ÃÀå Á¡À¯À²(%), 2025³â Áö¿ªº°
Vagus Nerve Stimulators Market-IMG1

¹ÌÁֽŰæÀº °¡Àå ±ä ³ú½Å°æÀ¸·Î, ½ÉÀåÀ» Æ÷ÇÔÇÑ ½ÅüÀÇ ¿©·¯ ±â°ü°ú »óÈ£ ÀÛ¿ëÇÕ´Ï´Ù. ¹ÌÁֽŰæÀڱؿä¹ý(VNS)Àº ¹ÌÁֽŰæÀڱرâ¶ó´Â À̽ÄÇü ÀÇ·á±â±â¸¦ »ç¿ëÇÏ¿© ¹ÌÁֽŰ濡 Àü±â ÆÞ½º¸¦ °ø±ÞÇÏ´Â °ÍÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ Ä¡·á¹ýÀº ¹ÌÁֽŰæÀ» ÀÚ±ØÇÏ¿© ³úÀÇ ºñÁ¤»óÀûÀΠȰµ¿À» Á¶ÀýÇÏ°í ¹ßÀÛÀ» ¾ïÁ¦ÇÒ ¼ö ÀÖ´Ù´Â ¿ø¸®¿¡ ±â¹ÝÇϰí ÀÖ½À´Ï´Ù. ¹ÌÁֽŰæ Àڱرâ´Â ¾à¼öó¸®·Î ÃæºÐÈ÷ Á¶ÀýµÇÁö ¾Ê´Â °£Áú ȯÀÚÀÇ ¹ßÀÛ ºóµµ¿Í ÁßÁõµµ¸¦ ÁÙÀ̱â À§ÇÑ º¸Á¶¿ä¹ýÀ¸·Î »ç¿ëµÇ¸ç, VNSÀÇ Ä¡·á °¡´É¼ºÀº ¿ì¿ïÁõ, ¾ËÃ÷ÇÏÀ̸Ӻ´, ÆíµÎÅë°ú °°Àº ´Ù¸¥ ½Å°æÁúȯ ¹× Á¤½ÅÁúȯÀÇ Ä¡·á¿¡µµ °ËÅäµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°è ¹ÌÁֽŰæÀڱر⠽ÃÀåÀº °£Áú ¹× ±âŸ ½Å°æÁúȯÀÇ À¯º´·ü Áõ°¡, VNS Ä¡·á¿¡ ´ëÇÑ Àνİú ¼ö¿ë¼º Áõ°¡, À¯¸®ÇÑ »óȯ Á¤Ã¥¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ¹ÌÁֽŰæ Àڱذú °ü·ÃµÈ ºÎÀÛ¿ë ¹× ÇÕº´Áõ°ú ÇÔ²² VNS Àåºñ ¹× ¼ö¼ú°ú °ü·ÃµÈ ³ôÀº ºñ¿ëÀÌ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¾ïÁ¦¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. °³¼±µÈ ±â´ÉÀ» °¡Áø Çõ½ÅÀûÀÎ ÀÚ±Ø ÀåºñÀÇ °³¹ß°ú VNSÀÇ Ä¡·á ¿ëµµ È®´ë´Â ¿µÇâ·Â ÀÖ´Â ·»´õ¸µÀÇ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌÇØ°ü°èÀÚµéÀº Ä¡·á ÀúÇ×¼º ¿ì¿ïÁõ, ·ù¸¶Æ¼½º °üÀý¿°, ½ÉºÎÀü µîÀÇ Áõ»ó¿¡¼­ VNSÀÇ È¿´ÉÀ» Æò°¡Çϱâ À§ÇÑ ¿¬±¸ ½ÃÇè¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ¹ÌÁֽŰæ Àڱر⠽ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¹ÌÁֽŰæ Àڱر⠽ÃÀå, Á¦Ç° À¯Çüº°, 2020-2032³â

Á¦6Àå ¼¼°èÀÇ ¹ÌÁֽŰæ Àڱر⠽ÃÀå, ¿ëµµº°, 2020-2032³â

Á¦7Àå ¼¼°èÀÇ ¹ÌÁֽŰæ Àڱر⠽ÃÀå, Àç·á À¯Çüº°, 2020-2032³â

Á¦8Àå ¼¼°èÀÇ ¹ÌÁֽŰæ Àڱر⠽ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â

Á¦9Àå ¼¼°èÀÇ ¹ÌÁֽŰæ Àڱر⠽ÃÀå, Áö¿ªº°, 2020-2032³â

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå ¾Ö³Î¸®½ºÆ®ÀÇ ½ÃÁ¡

Á¦12Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Vagus Nerve Stimulators Market is estimated to be valued at USD 667.4 Mn in 2025 and is expected to reach USD 1,293.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 667.4 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.90% 2032 Value Projection: USD 1,293.1 Mn
Figure. Vagus Nerve Stimulators Market Share (%), By Region 2025
Vagus Nerve Stimulators Market - IMG1

The vagus nerve is the longest cranial nerve that interacts with several organs of the body including the heart. Vagus nerve stimulation or VNS involves delivering electrical pulses to the vagus nerve using an implantable medical device called a vagus nerve stimulator. This therapy relies on the principle that stimulating the vagus nerve can help regulate abnormal brain activity and seizure control. Vagus nerve stimulators are used as an adjunctive therapy for reducing the frequency and severity of seizures in patients with epilepsy whose conditions are not fully controlled by medications. The therapeutic potential of VNS is being explored for treating other neurological and psychiatric disorders such as depression, Alzheimer's disease, and migraine too.

Market Dynamics:

The global vagus nerve stimulators market is driven by the rising prevalence of epilepsy and other neurological disorders, growing awareness and acceptance of VNS therapy, and favorable reimbursement policies. However, high costs associated with VNS devices and surgeries coupled with adverse effects and complications associated with stimulation of the vagus nerve act as key restraints for the market growth. Development of innovative stimulation devices with improved features and expanding therapeutic applications of VNS present high-impact rendering opportunities. Stakeholders are investing in research trials to evaluate the efficacy of VNS in conditions such as treatment-resistant depression, rheumatoid arthritis, and heart failure.

Key Features of the Study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Vagus Nerve Stimulators Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Vagus Nerve Stimulators Market, By Product Type, 2020 - 2032, (USD MN)

6. Global Vagus Nerve Stimulators Market, By Application, 2020 - 2032, (USD MN)

7. Global Vagus Nerve Stimulators Market, By Material Type, 2020 - 2032, (USD MN)

8. Global Vagus Nerve Stimulators Market, By End User, 2020 - 2032, (USD MN)

9. Global Vagus Nerve Stimulators Market, By Region, 2020 - 2032, (USD MN)

10. Competitive Landscape

11. Analyst View

12. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â